angelagonzalez

152 POSTS 0 COMMENTS

Repeat ablation with contact force sensing “does not necessarily guarantee a...

Preliminary results from the ABLATOR observational registry have shown similar success rates (around 58%) in first time ablation and repeat ablation for persistent atrial...

Cardiac resynchronisation therapy guided by imaging: The next step for optimal...

Jonathan Behar (London, UK) co-inventor for the Guide CRT platform—shortlisted as a 2017 finalist for the EHRA Inventors Award—details the benefits of this novel...

EHRA Inventors Award ideas focus on cardiac remote monitoring and CRT...

For the second-year running, the European Heart Rhythm Association (EHRA) held the EHRA Inventors Award competition at EHRA-EUROPACE CARDIOSTIM (18‒21 June, Vienna, Austria), a...

Saving lives with re-used cardiac implantable electronic devices

Behzad Pavri (Thomas Jefferson University Hospital, Philadelphia, USA) is an advocate for re-use of cardiac implantable electronic devices (CIEDs) as life-saving medical technology for...

The impact of the humanitarian EP

Inspired by the 2017 Heart Rhythm Society (HRS) Scientific Sessions opening plenary theme “Becoming a citizen of the world” and the key speaker, Hugh...

US FDA accepts Biologics License Application resubmission of reversal agent andexanet...

Portola Pharmaceuticals has announced that the US Food and Drug Administration (FDA) has found its resubmitted Biologics License Application andexanet alfa (AndexXa) to be...

Remote monitoring allows earlier diagnosis of asymptomatic arrhythmias in patients with...

The first study to assess the clinical impact of remote monitoring with the Reveal LINQ implantable loop recorder (Medtronic) has demonstrated the benefits of...

Update on treatment strategies for vasovagal syncope

When speaking on therapy of vasovagal syncope (VVS), it is important to stress that a specific treatment of VVS is only rarely necessary in...

Cardiac sympathetic denervation helps to reduce sustained ventricular tachycardia and ICD...

By Angela Gonzalez A retrospective study, including the largest series of patients with refractory ventricular tachycardia undergoing cardiac sympathetic denervation for structural heart disease, has...

Princess Grace Hospital publishes data demonstrating more rapid transmural lesion formation...

Stereotaxis and Princess Grace Hospital in Monaco have announced the publication of a study comparing the speed of lesion formation of magnetic catheters using the Niobe system to manually...

Pneumonia or sepsis in adults associated with increased risk of cardiovascular...

Pneumonia or sepsis in adults that results in hospital admission is associated with a six-fold increased risk of cardiovascular disease in the first year,...

CardioFocus receives approval for HeartLight Endoscopic Ablation System in Japan

CardioFocus has announced that the Japanese Ministry of Health, Labour and Welfare has approved the HeartLight Endoscopic Ablation System for the treatment of paroxysmal atrial fibrillation...

Heart Research UK funds UCL research to improve baby congenital heart...

National charity, Heart Research UK has granted funding for an innovative research project with University College London, UK, and Great Ormond Street Hospital, London,...

Long working hours associated with higher risk of atrial fibrillation

By Angela Gonzalez People working 55 hours or more a week had an approximately 40% higher risk of atrial fibrillation compared with people working 35...

Internists and geriatricians have insufficient understanding of implantable cardioverter defibrillator use

Physicians in internal medicine and geriatrics and even physicians working in cardiology departments lack basic knowledge of treatment with implantable cardioverter defibrillators (ICDs) and...

AliveCor and Mayo Clinic announce collaboration to develop artificial intelligence technology...

AliveCor has announced a collaboration with Mayo Clinic to develop tools for medical and non-medical personnel to easily screen for long QT syndrome (LQTS)...

The Heart Rhythm Society announces grant recipients of the 2017 AFib...

The Heart Rhythm Society (HRS) has announced eight US facilities to be awarded funding to support the development of the 2017 AFib Screening and...

Europace 2017: Thrombus formation on left atrial appendage occlusion devices strongly...

A French multicentre analysis of left atrial appendage (LAA) occlusion for stroke prevention in atrial fibrillation patients has found a 5.3% rate of thrombus...

Cardiac sympathetic denervation for treatment of ventricular arrhythmia: Where are we...

Chance M Witt and Christopher J McLeod (Rochester, USA) review current treatment of ventricular arrhythmias with cardiac sympathetic denervation.  What is cardiac sympathetic denervation? Most electrophysiologists...

Cardiac Rhythm News Issue 37 – June 2017 EU edition

Highlights: -Could etripamil nasal spray be a “game-changer” for paroxysmal supraventricular tachycardia? -Long detection in single-chamber ICDs decreases mortality and unnecessary shocks -Chance M Witt and Christopher...

Cardiac Rhythm News Issue 37 – June 2017 US edition

Highlights: -Could etripamil nasal spray be a "game-changer" for paroxysmal supraventricular tachycardia? -Long detection in single-chamber ICDs decreases mortality and unnecessary shocks -Chance M Witt and Christopher...

S-ICD technology continues to advance rapidly

The benefits of the Subcutaneous Implantable Cardioverter Defibrillator (S-ICD, Boston Scientific) over transvenous (TV)-ICD, including lower rates of lead-related complications and lower in-hospital complication...

Low risk of repeat infection in reimplanted cardiac devices

It is safe to reimplant a new cardiac device after the removal of an infected one, and repeat infection rates are low, a large...

Biotronik receives CE mark for 3 Tesla full-body MRIs with newest...

Biotronik has received CE mark approval for 3 tesla (T) full-body scans with its latest range of magnetic resonance (MR) conditional pacemaker systems, including...

Carlos Morillo

Carlos Morillo (Calgary, Canada) was one of the first physicians to document the potential of ablation of the pulmonary vein region as a strategy...

How safe is it to implant insertable cardiac monitors outside hospital...

Writing for Cardiac Rhythm News, Jan Steffel (Zurich, Switzerland) reviews current data and practice regarding safety of insertable cardiac monitors (ICMs) implantation in office...

HRS 2017: New implantable string subcutaneous defibrillator shows promise for sudden...

The use of a novel implantable string subcutaneous defibrillator (ISSD, Newpace) that has no can, and has been designed to be placed without the...

HRS 2017: Could etripamil nasal spray be a “game-changer” for paroxysmal...

A phase 2 trial (NODE-1) of a nasal spray formulation of etripamil (Milestone Pharmaceuticals) shows it is safe and effective at terminating paroxysmal supraventricular...

CRT optimisation: Why a sensor-based strategy may be the optimal solution

This video has been sponsored by LivaNova. Over the past two decades there have been several optimisation strategies, whether they are echo-guided or EKG-guided, aimed...

HRS 2017: Watchman prevents stroke even in high-risk patients: One-year follow-up...

Left atrial appendage closure with the Watchman device (Boston Scientific) is safe and effective at stroke prevention, with a high implant and sealing success,...

HRS 2017: Endovascular occlusion balloon inclusion during lead extraction reduces mortality

Patients who suffer superior vena cava tears (SVC) during lead extraction are more likely to survive when treatment includes an endovascular occlusion balloon, a...

HRS 2017: S-ICDs successful despite a range of comorbidities, and across...

Initial real-world experience with the S-ICD (subcutaneous implantable cardioverter defibrillator) in the USA show that implant success rate is high and short-term complications acceptably...

HRS 2017: Long detection in single chamber ICDs cuts mortality and...

Unnecessary shocks and all-cause mortality are reduced in patients treated with a single chamber implantable cardioverter defibrillator (ICD) programmed with a long detection window. Lead...

Abbott receives CE mark for its Confirm Rx insertable cardiac monitor...

Abbott has announced CE mark and first use of the new Confirm Rx ICM. According to a company release, this is the world’s first smartphone...

Remote monitoring of ICDs is more cost-effective than standard management

Remote monitoring of implantable cardioverter defibrillators (ICD), particularly in cardiac resynchronisation therapy (CRT-D), reduces direct healthcare costs compared with standard monitoring, an economic evaluation...

Rate of early death after ventricular tachycardia ablation as high as...

Early post-procedural mortality occurred in 5% of cases of radiofrequency catheter ablation in patients with scar-related ventricular tachycardia (VT), with more than half of...

Boston Scientific announces scheduled presentations at Heart Rhythm Society 2017

Boston Scientific has announced the schedule of key data presentations, including two late-breaking clinical trials that will be featured at the Heart Rhythm Society’s...

Surgical left atrial appendage occlusion reduces thromboembolic stroke and mortality in...

Surgical left atrial appendage occlusion (LAAO) is associated with a reduction of thromboembolism and all-cause mortality among older atrial fibrillation (AF) patients undergoing cardiac...

Acutus Medical receives FDA clearance for AcQGuide Steerable Sheath

Acutus Medical has announced the FDA clearance of the AcQGuide Steerable Sheath, which marks the first US regulatory milestone for the company. The AcQGuide Steerable...

Thomas F Deering

Thomas F Deering (Piedmont Heart Institute, Atlanta, USA) considers that the biggest challenge in electrophysiology (EP) is to “move from the volume to the...

Teleflex gets FDA 510(k) clearance for the Arrow AC3 Optimus Intra-Aortic...

Teleflex has announced 510(k) clearance from the US Food and Drug Administration (FDA) for its AC3 Optimus Intra-Aortic Balloon Pump (IABP).This device helps a weakened...

In memoriam: Mark E Josephson

Mark E Josephson, a pioneer of clinical cardiac electrophysiology (EP), passed away at the age of 73 on 11 January 2017 after a courageous...

SOLAECE to become LAHRS

At the last Latin American Society of Electrophysiology and Cardiac Stimulation (SOLAECE) Congress (Porto Alegre, Brazil, November 2016) the Executive Board of SOLAECE announced...

MADIT S-ICD global study enrols first patient to assess sudden cardiac...

Boston Scientific has initiated a worldwide study (MADIT S-ICD) that will evaluate the survival benefit of patients treated with the Emblem MRI Subcutaneous Implantable...

Syncope may increase risk of workplace accidents, job loss

Working-age people who have syncope have a higher risk of occupational accidents and job loss, compared to adults without the condition, according to new research...

Pacemakers with Closed Loop Stimulation programming help to reduce recurrence of...

Patients with refractory reflex vasovagal syncope who received a pacemaker programmed with Closed Loop Stimulation (DDD-CLS, algorithm from Biotronik) had a seven-fold reduction in...

Modular cardiovascular device communication: A step towards artificial intelligence to treat...

The implantable cardioverter defibrillator (ICD) is a well-established therapy for the prevention of sudden cardiac death. However, it is still associated with complications over...

ACC 2017: Uninterrupted dabigatran performs better than warfarin in atrial fibrillation...

Results from the RE-CIRCUIT study have shown that uninterrupted dabigatran (Pradaxa, Boehringer Ingelheim), was associated with fewer bleeding complications than uninterrupted warfarin before, during...

Registry shows positive results with new mechanical lead extraction device

An Italian prospective multicentre registry with a large study population has demonstrated the safety and efficacy of a new hand-powered bidirectional rotational mechanical lead...

Clinical study validates efficiencies of Stereotaxis Niobe ES system compared to...

Stereotaxis has reported results of a study conducted at Centre Hospitalier Universitaire (CHU) of Saint-Étienne, France, which validates the advantages of the Niobe ES magnetic navigation...

New research indicates “harmless” painkillers are associated with an increased risk...

According to a study published in European Heart Journal–Cardiovascular Pharmacotherapy, painkillers that are traditionally considered harmless by the general public are associated with increased...

AtriCure names US principal investigator for the CONVERGE IDE clinical trial

AtriCure has announced David B DeLurgio as the US principal investigator for the CONVERGE IDE clinical trial. DeLurgio is a cardiac electrophysiologist at Emory Healthcare in Atlanta, USA. He is...

First guideline for evaluating and managing syncope released in USA

The American College of Cardiology (ACC), the American Heart Association (AHA) and the Heart Rhythm Society (HRS) have recently released the first US guideline...

FDA clears Reveal LINQ Insertable Cardiac Monitor with TruRhythm Detection

The US Food and Drug Administration (FDA) has given 510(k) clearance to Medtronic for its Reveal LINQ Insertable Cardiac Monitor (ICM) with TruRhythm Detection. A...

Medtronic announces Medicare reimbursement for Micra Transcatheter Pacing System

Medtronic has announced that the US Centers for Medicare & Medicaid Services (CMS) has approved coverage for the Micra Transcatheter Pacing System (TPS). This...

Clinical trial rules should protect patients and results not operational details,...

Rules governing the conduct of clinical trials are failing to produce the intended benefits for patients and should be rewritten through a transparent process...

AF ablation associated with phrenic nerve injury: Is this complication now...

Phrenic nerve injury is a well-established complication of all types of atrial fibrillation (AF) ablation and is most common with balloon-based approaches, writes Hugh...

Cardiac resynchronisation therapy upgrade is less favourable than de novo implantations

Results from a large multicentre observational study have shown that patients undergoing cardiac resynchronisation therapy (CRT) upgrade had worse clinical response and long-term survival...

US FDA approves Abbott’s FlexAbility Catheter, Sensor Enabled

The FlexAbility Ablation Catheter, Sensor Enabled is designed to improve the versatility and precision during cardiac ablation procedures to treat atrial flutter. The Sensor Enabled...

Pacemaker function may be impacted by electric appliances

Electric and magnetic fields generated from everyday household appliances, electrical tools and more, used in very close proximity to the body, can interfere with...

Occlutech left atrial appendage occluder shows high procedural success in first-in-man...

The first-in-man study exploring the safety, feasibility and neurological outcome with the Occlutech left atrial appendage (LAA) occluder (Occlutech) has shown a 93% procedural...

Superior vena cava does not seem to contribute to long-standing persistent...

The arrhythmogenicity of the superior vena cava has been rarely detected in patients with long-standing persistent atrial fibrillation, according to study from China recently...

ADVERTORIAL: Experience with the ColumbusTM 3D EP Navigation System in the...

Electrophysiologists Manuel Ayala Patete, Dulce Garcia, Mikel Liñero, Vanesa Burgos and Carlos Garcia Lithgow, all from Centro Cardio-Neuro-Oftalmologico y Transplante (CECANOT) in Santo Domingo,...

Multielectrode mapping may be more effective than point-by-point mapping for VT...

Results from the first randomised study comparing multielectrode mapping vs. conventional point-by-point mapping for ventricular tachycardia (VT) substrate ablation procedures have shown that a...

US FDA approves Assurity MRI pacemaker

Abbott has announced US Food and Drug Administration (FDA) approval for magnetic resonance (MR)-conditional labelling for both the Assurity MRI pacemaker and the Tendril...

Biotronik launches a new series of Ilivia CRT devices

Biotronik has announced the launch of a new series of cardiac resynchronisation therapy (CRT) devices with several functionalities that allow physicians to offer an...

New multidisciplinary care pathway helps to reduce the risk of recurrent...

A growing body of evidence suggests that the underlying cause for many cryptogenic strokes is atrial fibrillation (AF). However, many of these patients do...

Educational Supplement ‒ St. Jude Medical: Tackling heart failure with innovative...

This educational supplement is only available in countries outside the USA. This educational supplement contains highlights of the 5th edition of The Future of Heart...

The WiSE CRT technology: A feasible and effective alternative to conventional...

In this case report, Timothy Betts (consultant cardiologist and electrophysiologist, Oxford University Hospitals NHS Foundation Trust, Oxford, UK) details the benefits of the WiSE...

AF Symposium 2017: First-in-man study shows promising results with a multi-electrode...

Results of AF-FICIENT, the first-in-man study which seeks to evaluate the safety and performance of the new Apama radiofrequency (RF) balloon catheter system (Apama...

AF Symposium 2017: Use of intracardiac echocardiography is a “viable option”...

Intracardiac echocardiograpy (ICE) facilitates a high success implant rate of the Amplatzer Amulet left atrial appendage (LAA) occluder (St Jude Medical/Abbott) as well as...

Few cardiologists take steps to avoid radiation exposure during pregnancy despite...

The Women in Cardiology (WIC) section of the American College of Cardiology (ACC) report that 47% of female cardiologists have avoided being pregnant during...

Abbott completes the acquisition of St Jude Medical

Abbott has now completed the acquisition of St Jude Medical. The Abbott press release announcing the completion of the acquisition said, “The transaction provides...

Advances in non-invasive imaging to treat ventricular tachycardia and prevent sudden...

We are standing at a crossroads of non-invasive imaging technologies in the field of electrophysiology. Advances in cardiac magnetic resonance imaging (CMRI) mean that...

Case strengthens for opportunistic atrial fibrillation screening

By Angela Gonzalez In the quest to reduce the number of atrial fibrillation (AF) related strokes, which account for a third of all ischaemic strokes,...

AHA 2016: Transcatheter atrial shunt benefits persist through one year in...

Twelve-month results of the REDUCE LAP HF (Reduce elevated left atrial pressure in patients with heart failure) trial have shown both continued device patency...

Christian Butter wins best abstract for SELECT-LV final trial results at...

Christian Butter (Heart Center Brandenburg, Bernau bei Berlin, Germany) was awarded best abstract at the XVII International Symposium on Progress in Clinical Pacing (29...

CASE REPORT: WiSE CRT technology ‒ a feasible and effective alternative...

This case report has been written by Timothy Betts (consultant cardiologist and electrophysiologist, Oxford University Hospitals NHS Foundation Trust, Oxford, UK) and has been sponsored by...

In search of innovative technologies for ventricular tachycardia ablation with cryoenergy

A proof-of-concept study has demonstrated that a new cryoablation system, which achieves “much cooler” temperatures than previous cryoablation technologies, is able to create large,...

Insights into current heart failure management

Piotr Ponikowski (Centre for Heart Disease, Clinical Military Hospital, Wroclaw, Poland), chairperson of the 2016 European Society of Cardiology (ESC) Guidelines for the diagnosis...

AHA 2016: Multisensor algorithm may help predict worsening heart failure

Results from the MultiSENSE study have demonstrated that a new multisensor algorithm, the HeartLogic Heart Failure Diagnostic Service (Boston Scientific), provides a timely alert...

“We still have a long way to go to understand the...

In light of the recently presented results from REM-HF and MORE-CARE trials, Gerhard Hindricks and Nikolaos Dagres, both from Leipzig University Heart Center, Leipzig,...

Trudie Lobban discusses “Detect – Protect – Correct” campaign for AF...

With the aim to help tackling the limitations of detecting atrial fibrillation (AF) across the globe with a simple pulse check and to raise...

AHA 2016: Low-dose rivaroxaban reduces clinically significant bleeding in PCI patients...

Two drug regimens involving low doses of rivaroxaban (Xarelto, Bayer)—one with a 15mg once daily dose of the drug and a P2Y12 inhibitor and...

OSYPKA AG launches HAT500® RF ablation system in Europe

OSYPKA AG has announced the launch of the HAT500® radiofrequency (RF) ablation system in Europe. The device received CE mark in October 2016. OSYPKA AG,...

AHA 2016: Elizabeth M McNally wins AHA prize for research into...

The American Heart Association (AHA) awarded its Basic Research Prize for 2016 to Elizabeth M McNally (Chicago, USA) for “Ground-breaking investigations of novel genetic...

AHA 2016: Combination of drug therapy and left ventricular assist device...

More than a third of advanced heart failure patients treated with a left ventricular assist device (LVAD) and intensive drug therapy have recovered their heart function enough...

Biotronik launches Inventra ICD for heart failure patients with higher defibrillation...

Biotronik has announced the US launch of Inventra HF-T, an implantable cardioverter defibrillator (ICD) that delivers “ultra-high” energy with 42 joules (J) on the...

Quadra Allure MP CRT-P gets CE mark approval for MRI labeling

St Jude Medical has announced CE mark approval for magnetic resonance (MR) conditional labeling for the company’s Quadra Allure MP cardiac resynchronisation therapy pacemaker (CRT-P). The...

First-in-human data demonstrate safety and efficacy of new lead for temporary...

A first-in-human study has shown that a new temporary lead for cardiac pacing (Tempo Lead, BioTrace Medical) is safe and effective for use in...

Charity believes NHS programme will leave hundreds of atrial fibrillation patients...

Arrhythmia Alliance, the UK-based heart rhythm charity, is calling on NHS England to reconsider a programme that it says will mean the “hundreds” of...

Acute and chronic performance of communicating leadless anti-tachycardia pacemaker and S-ICD

Martin Burke (CorVita Science Foundation, Chicago, USA) presents the preclinical acute and chronic performance of the combined implant of a leadless anti-tachycardia pacemaker and...

Commissioning through evaluation for LAAO in England

Dhiraj Gupta (Liverpool Heart and Chest Hospital, Liverpool, UK) discusses NHS England's commissioning through evaluation for left atrial appendage occlusion (LAAO). This programme is...

Patent foramen ovale closure is more effective than medical management in...

  Final results from the RESPECT trial found that percutaneously closing a patent foramen ovale (PFO) using the Amplatzer PFO Occluder (St Jude Medical) was...

AtriCure announces approval for the cryoICE platform in Japan

AtriCure has announced that it has received approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) for its cryoICE platform and CRYO2 cryoablation probe....

FDA approves Amplatzer PFO occluder device ahead of first report investigation...

The FDA has approved St Jude Medical’s Amplatzer patent foramen ovale (PFO) occluder device for the prevention of stroke. Announced on 28 October, this...

CardioFocus announces new management appointments

CardioFocus has announced the appointment of Omari Bouknight as chief commercial officer and Jeff Rynbrandt as vice president of US Sales. Together they will lead the commercialisation of...

Cardiac Rhythm News Issue 34 – October 2016

Highlights: -Rethink of ICD implantation in non-ischaemic heart failure may be on the cards -Remote monitoring for heart failure may not improve clinical outcomes -Stefan Spitzer: The...

Jeremy Ruskin

Jeremy Ruskin (Boston, USA), professor of medicine Harvard Medical School and director emeritus of the Cardiac Arrhythmia Service and Clinical Electrophysiology Laboratory at Mass...

Pre-clinical study indicates light could be used to treat ventricular arrhythmias

Tobias Brügmann (Institute of Physiology I, University of Bonn, Life and Brain Center, Bonn, Germany) and others report in The Journal of Clinical Investigation...

Interview with Richard Schilling ‒ president-elect of the British Heart Rhythm...

video
Cardiac Rhythm News speaks to Richard Schilling (St Bartholomews & The Royal London Hospital, London, UK), president-elect of BHRS (2017‒2019), about his objectives during...

Lifelong high endurance exercise may cause arrhythmias

A first-of-its-kind study has found that male veteran athletes have a significantly higher prevalence of arrhythmias such as atrial fibrillation, atrial flutter, sinus pauses,...

Lifelong high endurance exercise may cause arrhythmias

A first-of-its-kind study has found that male veteran athletes have a significantly higher prevalence of arrhythmias such as atrial fibrillation, atrial flutter, sinus pauses,...

Cryoballoon ablation demonstrates lower healthcare system costs compared to radiofrequency ablation

Analyses from the FIRE AND ICE trial has shown lower costs with cryoballoon catheter ablation compared to radiofrequency ablation—related to trial period—as a result...

Medtronic gets FDA approval for MRI compatible cardiac rhythm and heart...

Medtronic has announced US Food and Drug Administration (FDA) approval for its suite of cardiac rhythm and heart failure devices and leads to be...

FDA warns premature battery depletion in some ICD and CRT-D devices...

The Food and Drug Administration has recently issued a safety advisory communication regarding premature battery depletion associated with lithium deposits for some implantable cardioverter...

SentreHEART announces first clinical use of the Eclipse surgical left atrial...

  SentreHEART has announced it has treated the first patients using the Eclipse surgical device for left atrial appendage (LAA) closure. Krzysztof Bartus (Jagiellonian University,...

Heart Rhythm Congress (HRC) calls for urgent action to prevent thousands...

Heart Rhythm Congress (HRC), the UK’s largest educational congress devoted solely to heart rhythm disorders will gather over 3,000 heart rhythm experts and healthcare...

World Heart Federation launches global Roadmap to tackle atrial fibrillation

With the aim to help prevent atrial fibrillation (AF) and to improve its management worldwide— particularly in low- and middle-income countries—the World Heart Federation...

Painkillers linked to increased risk of heart failure

Commonly used prescribed painkillers for treating pain and inflammation are associated with an increased risk of hospital admission for heart failure, finds a study...

Mitac launches wearable ECG-sensor to monitor cardiac arrhythmias

Mitac Europe has announced the launch of its MiCor A100, an electrocardiograph wristband that measures heart rhythm and highlights symptoms of cardiac conduction abnormalities. According...

First US commercial atrial fibrillation procedure with HeartLight system performed at...

CardioFocus has announced the first commercial US procedure using its HeartLight Endoscopic Ablation system for the treatment of patients with paroxysmal atrial fibrillation (AF)...

New postgraduate programme aims to train future leaders in arrhythmia management

The European Heart Academy of the European Society of Cardiology (ESC), the European Heart Rhythm Association (EHRA) and the Maastricht University Medical Centre are...

Light could potentially be used to treat ventricular arrhythmias

Scientists from Johns Hopkins University and University of Bonn in Germany have found that beams of light could potentially replace  electric shocks to terminate ventricular...

ESC 2016: “User-friendly” risk score may help to better identify atrial...

A new risk score, based on data from GARFIELD-AF (Global anticoagulation registry in the field), may be superior to the CHA2DS2-VASc score at predicting...

JACC retracts OASIS trial paper

The Journal of the American College of Cardiology (JACC) has retracted the paper titled: “Impact of rotor ablation in non-paroxysmal atrial fibrillation patients: Results...

ESC 2016: Remote monitoring for heart failure may not improve clinical...

Two randomised clinical trials presented at a Hot Line session of the European Society of Cardiology Congress (ESC; 27‒31 August, Rome, Italy) have shown...

Daily alcohol consumption may lead to atrial fibrillation

Despite the common perception that moderate alcohol intake is good for the heart, new research suggests long-term alcohol consumption, even as little as one...

EBR Systems receives FDA approval to begin IDE study of its...

EBR Systems has announced the US Food and Drug Administration (FDA) has granted an Investigational Device Exemption (IDE) for its WiSE (Wireless Stimulation Endocardially) technology for cardiac...

What we know about retrieval of leadless pacemakers

Given the early in-human experience with leadless pacemakers, safety and effectiveness of chronic retrieval of such devices is still under question. Reinoud Knops (Amsterdam,...

No significant differences between Watchman and Amplatzer in first comparison

Results from the first study to compare outcomes of two left atrial appendage closure devices—Watchman (Boston Scientific) and Amplatzer (St Jude Medical)—indicate that there...

ESC 2016: Edoxaban is safe and effective in AF patients undergoing...

ENSURE-AF, the largest prospective, randomised clinical trial to date of anticoagulation for electrical cardioversion in non-valvular atrial fibrillation, has shown that edoxaban is an...

ESC 2016: Rethink of ICD implantation in non-ischaemic heart failure may...

Implantable cardioverter-defibrillators (ICDs) do not improve overall long-term survival compared to medical treatment in patients with non-ischaemic systolic heart failure, according to results of...

Results of phase 3b ENSURE-AF study investigating edoxaban in AF patients...

Daiichi Sankyo has announced it will present the first results from ENSURE-AF, the largest prospective randomised clinical trial to date evaluating a non-vitamin K...

First risk score developed for preventing sudden cardiac death in the...

Researchers in the USA have identified the first generalisable risk score for sudden cardiac death. This prediction model, the researchers argue, provides well-calibrated, absolute...

King’s College London joins with Cambridge Design Partnership to further develop...

Cambridge Design Partnership recently announced it is working with Kings College London to further develop a new steerable catheter designed to treat complex cardiac...

Bristol-Myers Squibb and Pfizer to present new apixaban analyses at ESC

Bristol-Myers Squibb and Pfizer have announced that 19 abstracts (late-breaking, rapid-fire, oral and poster presentations) on apixaban (Eliquis) will be presented at the European...

Thrombosis Research Institute to announce new real-world GARFIELD-AF registry insights in...

New analyses from the Global Anticoagulant Registry in the Field-Atrial Fibrillation (GARFIELD-AF) will be presented at the European Society of Cardiology (ESC) Congress (27‒31...

Educational supplement: LAA closure for stroke prophylaxis in atrial fibrillation

This educational supplement is only for readers in countries outside France, Japan and the USA In this educational supplement, sponsored by Boston Scientific, Cardiac Rhythm News explores left...

Increased parental longevity associated with lower risk of cardiovascular risk in...

Researchers in the United Kingdom (working with colleagues in Connecticut, France and India) examined 186,151 non-adopted participants aged 55‒73 years with deceased parents who...

Arca Biopharma announces 100th patient randomised into the GENETIC-AF phase 2b/3...

ARCA Biopharma has announced that the 100th patient has been randomised into GENETIC-AF, a seamless design phase 2B/3 clinical trial evaluating Gencaro (bucindolol hydrochloride)...

MultiPoint™ pacing CRT technology shows promise in improving heart failure responder...

A growing body of evidence, including the most recent randomised clinical trial results presented at HRS and CARDIOSTIM-EHRA EUROPACE, has shown that cardiac resynchronisation...

Boehringer Ingelheim launches RE-VECTO global programme to explore idarucizumab use in...

Boehringer Ingelheim has announced the launch of its global RE-VECTO programme for idarucizumab (Praxbind), the specific reversal agent for dabigatran etexilate (Pradaxa). Idarucizumab is approved...

Automated external defibrillator accessibility: Barrier during cardiac arrest

There is just a one in five chance that a potentially life-saving automated external defibrillator (AED) will be nearby when someone experiences cardiac arrest...

Biosense Webster announces US launch of ThermoCool SmartTouch SF catheter

Biosense Webster has announced the US launch of the ThermoCool SmartTouch SF catheter. According to a company release, the catheter pairs contact force technology...

Osypka AG launches 8mm gold-tipped Cerablate Flutter ablation catheter

According to a company release, the new device is ideal for maximum voltage guided ablation of atrial flutter. The Cerablate Flutter is a newly designed...

The OASIS trial: A critical appraisal

Recent results of the first randomised trial—OASIS trial—to compare rotor-only ablation with two other ablation strategies in non-paroxysmal atrial fibrillation patients found poor outcomes...

American Academy of Neurology advises not to routinely offer percutaneous PFO...

  A practice advisory update from the American Academy of Neurology (AAN) suggests that percutaneous patent foramen ovale (PFO) closure to patients with cryptogenic ischaemic...

Cardiac resynchronisation therapy with SonR automated feature helps to reduce hospitalisation...

Results from the RESPOND-CRT trial have shown a 35% risk reduction in hospitalisation at two years for heart failure patients implanted with cardiac resynchronisation...

Mediterranean diet without low-fat element reduces cardiovascular events

Hanna E Bloomfield (Minneapolis VA Medical Center, Minneapolis, USA) and others report in Annals of Internal Medicine that limited evidence, from randomised control trials, indicates...

Sudden cardiac death is the most common cause of death in...

An analysis from the ENGAGE AF-TIMI 48 trial has found that sudden cardiac death was the single most common cause of death and accounted...

Relevance of imaging for ventricular tachycardia ablation

Cardiac imaging has emerged as an integral part of mapping and ablation in a variety of complex arrhythmias. Advances in imaging techniques, especially the...

Insights into genetically-targeted prevention of atrial fibrillation in heart failure patients

The current need for new preventative therapies of atrial fibrillation in chronic heart failure patients—with fewer side effects than currently available treatment strategies—has led...

Cardiac Rhythm News Issue 33 – June 2016 EU Edition

Highlights: -Ablation should be "preferred approach" in drug-resistant ventricular tachycardia -First randomised trial shows "poor outcomes" with rotor ablation -Guilherme Fenelon: Ablation in Chagas disease -Pier Lambiase: EP...

Cardiac Rhythm News Issue 33 – June 2016 US Edition

Highlights: -Ablation should be "preferred approach" in drug-resistant ventricular tachycardia -First randomised trial shows "poor outcomes" with rotor ablation -Guilherme Fenelon: Ablation in Chagas disease -Pier Lambiase: EP...

Many drugs can cause or worsen heart failure, American Heart Association...

Commonly used medications and nutritional supplements may cause or worsen heart failure, according to the first scientific statement from the American Heart Association to...

Texas Children’s Hospital is the first paediatric institution in USA to...

Stereotaxis has announced that Texas Children’s Hospital in Houston, USA, has installed the its Niobe ES system, which according to the company, is the only...

Ablation of frequent premature ventricular complex allows safe withholding of ICD...

Patients with frequent premature ventricular complex and primary prevention implantable cardioverter defibrillator (ICD) indication who undergo ablation may be able to avoid ICD implant,...

Afibmatters.org now in Swedish and Portuguese

The European Heart Rhythm Association (EHRA) is launching the patient- and caregiver-oriented website afibmatters.org in Swedish and Portuguese. Afibmatters.org aims to contribute to improvements in...

Rethink of ICD implantation in non-ischaemic heart failure may be on...

Implantable cardioverter-defibrillators (ICDs) do not improve overall long-term survival compared to medical treatment in patients with non-ischaemic systolic heart failure, according to results of...

EHRA Proctor Programme applications now open

The European Heart Rhythm Association 
(EHRA) invites EHRA current and past winners of the Training Fellowship Programmes or established physicians wanting to acquire additional...

Call for 2016 EHRA membership renewal

The European Heart Rhythm Association (EHRA) invites its current members to renew their memberships for 2016 and invites cardiac rhythm management and electrophysiology experts,...